Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The Discovery and Development of Human GLP-1 Product details Product details Edition: 1 Latest edition Published: March 3, 2026 Language: English About the author About the author JH Jens Juul Holst Jens Juul Holst is Professor of Medical Physiology at the Department of Biomedical Sciences, University of Copenhagen
Subjects with a history of endocrine disorders were excluded, and other exclusion criteria were standard for a clinical pharmacology study in healthy subjects
Mucosal streaking develops with continued growth
Additionally, some IBS patientsparticularly those with IBS-C (constipation-predominant)may experience worsening of slow transit and constipation when starting GLP-1 medications, as these drugs naturally slow gastric emptying
The purpose of this article is to provide a comprehensive, medically grounded exploration of how Ozempic and similar GLP-1 medications may influence IBS symptoms
One more example
